Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

Fabricantes de medicamentos genéricos y especializados

Mr. Slobodan  Radumilo

Senior Vice President & Pres of International

Mr. Tom  Blount

Senior Vice President & Pres of North America

Mr. Ajay  Kumar

Senior Vice President & Chief HR Officer

Mr. Devdatt  Kurdikar

Pres, Chief Executive Officer & Director

Mr. Jacob P. Elguicze

Senior Vice President & Chief Financial Officer

Mr. Jeffrey Z. Mann

Senior Vice President, Gen. Counsel, Head of Corporation Devel. & Corp. Sec.

Mr. Shaun  Curtis

Senior Vice President of Global Manufacturing & Supply Chain

Mr. Brian R. Capone

Vice President, Chief Accounting Officer & Corporation Controller

Ms. Colleen  Riley

Senior Vice President & Chief Technology Officer

Mr. Pravesh  Khandelwal

Vice President & Head of Investor Relations

Ms. Ginny  Blocki

Senior Vice President of Global Marketing & Product Management

Nombre	Capitalización
China Medical System Holdings Limited	0M
CanSino Biologics Inc.	0M
Bod Science Limited	0M
Aion Therapeutic Inc.	0M
Canzon Israel Ltd	0M
Lincoln Pharmaceuticals Limited	0M
MGC Pharmaceuticals Limited	0M
CannLabs, Inc.	0M
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.	0M

Embecta Corp.

Embecta Corp. Lista de competidores

Principales competidores